title: Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study.
authors.affiliation: Jewish General Hospital, Montreal, Canada.
authors.forename: M A
authors.initials: MA
authors.lastname: Wainberg
authors.forename: M
authors.initials: M
authors.lastname: Tremblay
authors.forename: R
authors.initials: R
authors.lastname: Rooke
authors.forename: N
authors.initials: N
authors.lastname: Blain
authors.forename: H
authors.initials: H
authors.lastname: Soudeyns
authors.forename: M A
authors.initials: MA
authors.lastname: Parniak
authors.forename: X J
authors.initials: XJ
authors.lastname: Yao
authors.forename: X G
authors.initials: XG
authors.lastname: Li
authors.forename: M
authors.initials: M
authors.lastname: Fanning
authors.forename: J S
authors.initials: JS
authors.lastname: Montaner
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D002170:Canada / Q000453:epidemiology; D002478:Cells, Cultured; D004352:Drug Resistance, Microbial / Q000235:genetics; D014644:Genetic Variation; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007700:Kinetics; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000382:microbiology; D008562:Membrane Glycoproteins / Q000378:metabolism; D009705:Nucleosides / Q000494:pharmacology* / Q000627:therapeutic use; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D012680:Sensitivity and Specificity; D014759:Viral Envelope Proteins / Q000378:metabolism; D015215:Zidovudine / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D008562:Membrane Glycoproteins; D009705:Nucleosides; D014759:Viral Envelope Proteins; D015215:Zidovudine; D012194:RNA-Directed DNA Polymerase